SCHEMBL7659407

SCHEMBL7659407

[CH]1NC=CC2=C1CCC=C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27495036 0.65
SCHEMBL2843243 0.65
SCHEMBL16423308 0.64 ALDH1A1 (0.36)
SCHEMBL12810075 0.61
SCHEMBL2506587 0.61
SCHEMBL2497308 0.60
SCHEMBL13781975 0.57
SCHEMBL815142 0.56
SCHEMBL816417 0.56 ALDH1A1 (0.31)
SCHEMBL817441 0.56 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001056974-A2 INHA INHIBITORS AND THEIR USE AS ANTIBACTERIALS GENZYME CORPORATION (US) 2001-08-09 WO claimed
US-6372752-B1 ENZYME INHIBITORS, RESPIRATORY SYSTEM DISORDERS, TUBERCULOSIS AND MYCOBACTERIUM BACTERICIDES GENZYME CORPORATION 2002-04-16 US disclosed
WO-2001056974-A2 INHA INHIBITORS AND THEIR USE AS ANTIBACTERIALS GENZYME CORPORATION (US) 2001-08-09 WO disclosed